Marché du traitement des infections des voies urinaires – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00005931
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 241
Buy Now

[Rapport de recherche]Le marché devrait atteindre 11 614,32 millions de dollars américains d'ici 2027, contre 9 106,40 millions de dollars américains en 2019 ; on estime qu'il croîtra à un TCAC de 3,2 % de 2020 à 2027.



La croissance du marché est attribuée à la prévalence croissante des infections des voies urinaires, au vieillissement de la population et aux technologies informatiques émergentes pour le diagnostic urinaire. Cependant, le manque de notoriété du produit dans les pays émergents et les effets associés aux médicaments entravent dans une certaine mesure la croissance du marché du traitement des infections des voies urinaires.



Des marchés régionaux lucratifs pour le traitement des infections des voies urinaires



< h3>Aperçu du marché

Incidence croissante des infections des voies urinaires



Les femmes courent un risque plus élevé de développer des infections des voies urinaires (IVU) que les hommes. Les infections urinaires, si elles ne sont pas traitées, peuvent entraîner des douleurs intenses et de graves conséquences pour les reins. Les infections urinaires présentent certains symptômes tels qu'une envie persistante d'uriner, une inflammation, un changement d'apparence de l'urine et des nausées. La prévalence croissante des infections urinaires est l'un des principaux facteurs de croissance du marché du traitement des infections des voies urinaires. Par exemple, selon une étude menée par un groupe de chercheurs de l'American College of Physicians and Infectious Diseases Society of America en 2020, les infections urinaires représentent environ 6 millions de visites de médecins chaque année aux États-Unis.



Certains facteurs de risque tels que l'activité sexuelle, une mauvaise hygiène et le vieillissement peuvent provoquer des infections urinaires. On estime également que l'incidence croissante de ces facteurs de risque stimulera la croissance du marché du traitement des infections des voies urinaires d'ici 2027. Selon une étude publiée dans l'International Journal of Environmental Research and Public Health en 2019, les patients souffrant de maladies chroniques existantes telles que la maladie coronarienne ( CAD), l'insuffisance rénale chronique (IRC) et le diabète sucré (DM) ont de fortes possibilités de contracter des infections urinaires. Par conséquent, l'épidémiologie élevée des infections urinaires génère une demande pour ses produits de traitement, entraînant finalement la croissance du marché.



Informations basées sur la classe de médicaments



Sur la base de la classe de médicaments, le segment des quinolones détenait le plus grand part de marché en 2019 ; Cependant, le segment pénicilline et combinaison devrait enregistrer le TCAC le plus élevé de 4,5 % sur le marché au cours de la période de prévision. La croissance future du marché des quinolones est principalement attribuée au fait qu'elle est le plus souvent prescrite par les médecins. La ciprofloxacine, la lévofloxacine et l'énoxacine sont parmi les médicaments les plus largement utilisés pour le traitement. h3>

Le marché du traitement des infections urinaires, par indication, est segmenté en infections urinaires compliquées et infections urinaires simples. Le segment des infections urinaires compliquées détenait une plus grande part de marché en 2019 ; De plus, le segment devrait enregistrer un TCAC plus élevé sur le marché au cours de la période de prévision.



Informations basées sur les canaux de distribution



Le marché du traitement des infections des voies urinaires, par canal de distribution, est segmenté en pharmacies hospitalières, cliniques de gynécologie et d'urologie, pharmacies, pharmacies de détail et pharmacies en ligne. Le segment des canaux de distribution des pharmacies hospitalières détenait la plus grande part du marché en 2019, tandis que le segment des pharmacies en ligne devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Perspectives stratégiques



< p>Les acteurs du marché du traitement des infections des voies urinaires, tels que Shionogi & Co., Ltd. ; Teva Pharmaceutical Industries Ltd; Allergan; et Pfizer ont adopté plusieurs stratégies organiques et inorganiques pour améliorer leurs revenus et leur position sur le marché. Par exemple, en avril 2019, Teva Pharmaceutical Industries Ltd a annoncé le lancement d'une version générique des comprimés VESIcare (succinate de solifénacine), 5 mg et 10 mg, aux États-Unis.



Marché du traitement des infections des voies urinaires - par Classe de médicaments




  • Pénicilline et combinaisons

  • Quinolones

  • Céphalosporine

  • Antibiotiques aminosides

  • Sulfamides
  • Suppléments nutritionnels


Marché du traitement des infections des voies urinaires - par indication




  • Infection urinaire compliquée

  • Voies urinaires non compliquées Infection


Marché du traitement des infections des voies urinaires - par canal de distribution




  • Pharmacies hospitalières

  • Cliniques de gynécologie et d'urologie

  • Pharmacies de détail et pharmacies

  • Pharmacies en ligne


Marché du traitement des infections des voies urinaires - par géographie




  • Amérique du Nord

    • États-Unis

    • Canada

    • Mexique



  • Europe

    • France

    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne

    • Reste de l'Europe



  • Asie-Pacifique (APAC)

    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie

    • < li>Reste de l'Asie-Pacifique


  • Moyen-Orient et Afrique (MEA)

    • Afrique du Sud

    • Arabie saoudite

    • < li>EAU
    • Reste du Moyen-Orient et Afrique



  • Amérique du Sud et centrale

    • Brésil

    • Argentine

    • Reste de l'Amérique du Sud et centrale




Profils des entreprises




  • Teva Pharmaceutical Industries Ltd< /li>
  • Sun Pharmaceutical Industries Ltd

  • Mylan NV

  • ALLERGAN

  • Pfizer Inc.

  • Cipla Ltd

  • F. Hoffmann-La Roche Ltd

  • Shionogi Inc.

  • Amway

  • DuPont Nutrition & Biosciences


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies - Urinary Tract Infection Treatment Market

 

  1. Teva Pharmaceutical Industries Ltd
  2. Sun Pharmaceutical Industries Ltd
  3. Mylan N.V.
  4. ALLERGAN
  5. Pfizer Inc.
  6. Cipla Ltd
  7. F. Hoffmann-La Roche Ltd
  8. Shionogi Inc.
  9. Amway
  10. DuPont Nutrition & Biosciences

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports